SO
LOGC

STRS Ohio’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

STRS Ohio’s Portfolio LOGC Stock Details LOGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,200
Closed -$18K – 2312
2020
Q2 		$18K Hold
2,200
– – ﹤0.01% 2058
2020
Q1 		$10K Hold
2,200
– – ﹤0.01% 1940
2019
Q4 		$15K Hold
2,200
– – ﹤0.01% 1994
2019
Q3 		$23K Hold
2,200
– – ﹤0.01% 1969
2019
Q2 		$28K Hold
2,200
– – ﹤0.01% 2000
2019
Q1 		$21K Hold
2,200
– – ﹤0.01% 1964
2018
Q4 		$22K Buy
+2,200
New +$26.6K ﹤0.01% 1979

Other funds holding LOGC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

STRS Ohio's LOGC Position: Q3 2020 in Review

STRS Ohio sold out of LogicBio Therapeutics, Inc. Common Stock (LOGC) in Q3 2020, closing a stake of 2,200 shares — an estimated $18K sold.

STRS Ohio first reported a position in LOGC in Q4 2018 and held it in 7 quarters. The position peaked at $28K in Q2 2019. 51 funds tracked by Wall St. Rank hold LOGC as of Q3 2020.

  • STRS Ohio reported no remaining LogicBio Therapeutics, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • STRS Ohio sold 2,200 LogicBio Therapeutics, Inc. Common Stock shares in Q3 2020, an estimated $18K.
  • STRS Ohio first reported a position in LogicBio Therapeutics, Inc. Common Stock in Q4 2018 and held it in 7 quarters.
  • STRS Ohio's LogicBio Therapeutics, Inc. Common Stock position peaked at $28K in Q2 2019.
  • 51 funds tracked by Wall St. Rank held LogicBio Therapeutics, Inc. Common Stock as of Q3 2020.

Based on STRS Ohio's 13F filing for Q3 2020, filed 14 Dec 2020.